News Breaks |
|
|
| September 4, 2012 |
| 08:52 EDT |  | MDVN, JNJ | Medivation Xtandi appears superior to J&J's Zytiga, says Leerink
After Medivation's (MDVN) Xtandi was approved as a treatment for some cases of prostate cancer, Leerink Swann believes that the product's efficacy is superior to that of a competing drug from Johnson &Johnson (JNJ). The firm maintains an Outperform rating on Medivation. |
|
|
News For MDVN;JNJ From The Last 14 Days Check below for free stories on MDVN;JNJ the last two weeks. |
|
|
| May 17, 2013 |
| 06:19 EDT |  | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
 Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT |  | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| May 14, 2013 |
| 14:59 EDT |  | MDVN | Medivation has a conference call hosted by JPMorgan
JPMorgan Analysts Meacham and Kasimov host a conference call with CEO David Hung on May 16 at 10 am. |
|
| May 10, 2013 |
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 06:16 EDT | | JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT | | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 16:23 EDT |  | MDVN | Medivation sees FY13 operating expenses, net of Astellas payments, $285M-$300M
Subscribe for More Information |
|
| 16:23 EDT | | MDVN | Medivation reports Q1 EPS (36c), consensus (41c)
Reports Q1 revenue $46.15M, consensus $38.54M. |
|
| 15:27 EDT | | MDVN | Notable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include priceline.com (PCLN), consensus $5.27; Public Storage (PSA), consensus $1.62; NVIDIA (NVDA), consensus 10c; CareFusion (CFN), consensus 53c; Assured Guaranty (AGO), consensus 68c; Medivation (MDVN), consensus (41c); Great Plains Energy (GXP), consensus 12c; Salix Pharmaceuticals (SLXP), consensus 68c; Air Lease (AL), consensus 38c; Sotheby's (BID), consensus (12c). |
|
| 09:51 EDT | | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
| |
| May 8, 2013 |
| 07:38 EDT | | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 6, 2013 |
| 11:29 EDT | | JNJ | J&J cosmetics license revoked at Mumbai plant, Reuters says
Subscribe for More Information |
|
| 09:38 EDT | | MDVN | Medivation Xtandi estimates raised at Leerink
Subscribe for More Information |
|
| 07:24 EDT | | JNJ | Drug companies attempt to make painkillers that can't be abused, WSJ reports
Subscribe for More Information |
|
|
|
|
|
